Propranolol Dosing for Ventricular Arrhythmia
For ventricular arrhythmias, administer propranolol 0.5 to 1 mg IV over 1 minute, repeated as needed up to a total dose of 0.1 mg/kg (approximately 7 mg for a 70 kg patient). 1
IV Bolus Administration
The 2010 AHA ACLS Guidelines provide clear dosing for propranolol in ventricular arrhythmias 1:
- Initial dose: 0.5 to 1 mg IV push over 1 minute
- Repeat dosing: Can repeat every 1-2 minutes as needed
- Maximum total dose: 0.1 mg/kg (typically 7-10 mg for average adult)
- Onset of action: Within 5 minutes 2
Key contraindications to avoid: Asthma, obstructive airway disease, decompensated heart failure, and pre-excited atrial fibrillation or flutter 1.
Clinical Context and Mechanism
Propranolol is indicated for certain forms of polymorphic VT, particularly those associated with acute ischemia, familial long QT syndrome, or catecholaminergic polymorphic VT 1. The FDA label confirms efficacy in approximately 50% of patients with ventricular arrhythmias, with many reverting to normal sinus rhythm or experiencing reduced ventricular rate 2.
The antiarrhythmic effect occurs through both beta-blockade and direct membrane-stabilizing properties. Research demonstrates that while beta-blocking concentrations (25-150 ng/ml) are effective in most responders, some patients require higher concentrations (>500 ng/ml) for arrhythmia suppression 3. However, near-maximal beta-blockade is achieved at plasma concentrations around 150 ng/ml 3.
Continuous Infusion (If Needed)
While not standard for ventricular arrhythmias, if continuous control is required after initial boluses 4:
- Loading dose: 52 mcg/kg IV
- Maintenance infusion: 16-75 mcg/kg/hr, titrated to clinical response
- Monitor for hypotension and bradycardia
Transition to Oral Therapy
Once arrhythmia is controlled and patient is stable:
- Oral maintenance: 80-240 mg daily in divided doses 5
- Typical starting dose: 40 mg three to four times daily
- Titrate based on response and tolerability
Critical Safety Considerations
Monitor closely for:
- Hypotension - most common adverse effect
- Bradycardia - dose-dependent
- Heart failure precipitation - especially in patients with pre-existing LV dysfunction
- Bronchospasm - contraindicated in asthma/COPD
Common pitfall: Using propranolol in pre-excited atrial fibrillation (WPW syndrome) can paradoxically increase ventricular rate by eliminating concealed retrograde conduction in the accessory pathway 6. Always verify rhythm is ventricular in origin, not pre-excited supraventricular.
Special Populations
For electrical storm refractory to selective beta-blockers, propranolol at higher doses (up to 400 mg/day orally) combined with amiodarone has shown efficacy 7. The non-selective beta-blockade may provide additional benefit through mechanisms independent of beta-1 receptor blockade 8.
In Brugada syndrome specifically: Propranolol can aggravate VF induction and should be avoided; isoproterenol is preferred 9.